![Yvonne Perlberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yvonne Perlberg
Direttore/Membro del Consiglio presso EnGeneIC Pty Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Jennifer A. MacDiarmid | M | - |
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | 23 anni |
Himanshu Brahmbhatt | M | - |
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | 23 anni |
Edward Miller | M | 81 |
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | 8 anni |
Mervyn Turner | M | 77 |
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | - |
Richard Woods | M | - |
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | - |
Mark L. Levitt | M | - |
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Australia | 6 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Yvonne Perlberg
- Contatti personali